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A Lung Cancer Screening Personalized Decision-aid Improves Knowledge and
Reduces Decisional Conflict Among a Diverse Population of Smokers at an Urban
Academic Medical Center
Abstract
Introduction
Introduction: Few lung cancer screening decision aids have been tested in diverse populations. The study
objective was to determine whether the online decision aid www.shouldiscreen.com impacts knowledge
of and decisional conflict around lung cancer screening in a diverse population.
Methods
Methods: Eligible patients had significant smoking histories, were at increased risk for lung cancer (ages
45-80, >20 pack-years, smoking within last 15 years) and had no history of prior lung cancer or screening.
Data was collected and analyzed in 2017.
Results
Results: 40 patients were enrolled: 80% were female, 62.5% black, 33% white, and 48% had a high school
education or less. 80% were current smokers with a mean of 34 pack-years accumulated. 35% were
eligible for screening by U.S. Preventive Services Task Force criteria. After reviewing the decision aid,
knowledge increased in all categories including risk factors for lung cancer (3.58 to 4.30, p<0.01), benefits
of screening (1.58 to 2.30, p<0.01), possible harms of screening (0.93 to 2.08, p<0.01), and eligibility for
screening (2.10 to 2.65, p<0.01). Decisional conflict was reduced from 21.25 to 8.65 (p<0.01). After use of
the decision aid, more patients expressed a preference not to be screened for lung cancer, such that
concordance with USPSTF guidelines decreased among those who were eligible to screen increased
among those who did not yet meet eligibility criteria; however, this finding was not statistically significant.
Conclusions
Conclusions: Even brief, unguided use of this web-based tool improved knowledge and reduced
decisional conflict for a diverse group of smokers considering lung cancer screening.
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ABSTRACT
Introduction: Few lung cancer screening decision aids have been tested in diverse populations.
The
study
objective
was
to
determine
whether
the
online
decision
aid www.shouldiscreen.com impacts knowledge of and decisional conflict around lung cancer
screening in a diverse population.
Methods: Eligible patients had significant smoking histories, were at increased risk for lung
cancer (ages 45-80, >20 pack-years, smoking within last 15 years) and had no history of prior lung
cancer or screening. Data was collected and analyzed in 2017.
Results: 40 patients were enrolled: 80% were female, 62.5% black, 33% white, and 48% had a
high school education or less. 80% were current smokers with a mean of 34 pack-years
accumulated. 35% were eligible for screening by U.S. Preventive Services Task Force criteria.
After reviewing the decision aid, knowledge increased in all categories including risk factors for
lung cancer (3.58 to 4.30, p<0.01), benefits of screening (1.58 to 2.30, p<0.01), possible harms of
screening (0.93 to 2.08, p<0.01), and eligibility for screening (2.10 to 2.65, p<0.01). Decisional
conflict was reduced from 21.25 to 8.65 (p<0.01). After use of the decision aid, more patients
expressed a preference not to be screened for lung cancer, such that concordance with USPSTF
guidelines decreased among those who were eligible to screen increased among those who did not
yet meet eligibility criteria; however, this finding was not statistically significant.
Conclusions: Even brief, unguided use of this web-based tool improved knowledge and reduced
decisional conflict for a diverse group of smokers considering lung cancer screening.
Keywords: shared decision making; lung cancer; urban health; health disparities; cancer
screening, decision aid
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INTRODUCTION
For many years, screening programs for breast, cervical, and colorectal cancer have
enjoyed the privilege of generally well-publicized and understood screening practices. As such,
many individuals at highest risk for mortality have been screened through mammography, pap
smears, and colonoscopy. However, few such organized efforts exist for lung cancer, the second
most common cause of cancer and the most common cause of cancer deaths in both men and
women in the United States (American Cancer Society, 2016). Lung cancer is often diagnosed at
late stages and carries a high but modifiable mortality. The aim of this study was to better
understand how to educate patients about lung cancer screening harms and potential benefits.
Specifically, we evaluated the efficacy of one online decision aid in improving knowledge of and
reducing decisional conflict around lung cancer screening.
The field of lung cancer screening has changed significantly over the past decade since the
National Lung Screening Trial demonstrated a 20% reduction in mortality with annual low-dose
computed tomography (LDCT) in patients at high risk for lung cancer (National Lung Screening
Trial Research Team, 2011). Based on these trials, the United States Preventative Services Task
Force (USPSTF) currently recommends annual screening for lung cancer with LDCT in adults
ages 55-80 who have a 30 pack-year smoking history and currently smoke or quit within the last
15 years (Moyer, 2014). Once high-risk individuals have been identified and referred for
screening, they must undergo shared decision-making so as to understand the benefits and risks of
screening, including false-positives, incidental findings, over diagnosis, and radiation risk. Shared
decision making is recommended by the USPSTF, American Cancer Society, American Academy
of Family Physicians, National Comprehensive Cancer Network, and others (U.S. Preventative
Services Task Force, 2016). In fact, the Center for Medicare and Medicaid Services mandates that
shared decision-making occur as a stipulation of lung cancer screening reimbursement (U.S.
Center for Medicare and Medicaid Services, 2015).
Implementation of shared decision making about lung cancer screening has various
challenges including low patient and provider awareness of the guidelines (Lewis, 2015), limited
time during clinician visits, and variability of the process of shared decision making. A 2018 study
observed a small sample of recorded conversations about initiating lung cancer screening in which
physicians did not use decision aids (Brenner et al., 2018). They found that the quality of shared
decision making was poor and the discussion of the harms of screening was minimal. Several
shared decision-making tools have been developed to improve the quality of such conversations
(Reuland et al., 2018). An initial educational video-based decision aid was acceptable to patients
and generally increased knowledge of lung cancer screening, but was not individualized and did
not aid patients in making specific decisions (Volk et al., 2014). More recently, a web-based
decision aid (www.shouldiscreen.com) was developed which describes individual cancer risks and
screening impact given user-entered patient demographics (Lau et al., 2013). This tool was tested
and shown to be acceptable to users, increase knowledge and concordance with USPSTF
guidelines, and decrease decisional conflict. However, this was studied in a population of 60
patients in Michigan in which 88% were white, 63% had at least a college degree, and only 18%
were actually eligible for screening by USPSTF guidelines (Lau et al., 2015). Therefore, use of
this decision aid should also be assessed among minority populations and those of lower
socioeconomic status, such as Philadelphia.
This study sought to assess the efficacy of the online decision aid
(www.shouldiscreen.com) by replicating the study in a more ethnically and socioeconomically
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diverse sample of patients. Our main aim was to understand how this online tool impacts
knowledge of and decisional conflict around screening. Effective tools for shared-decision making
are necessary for implementation of future lung cancer screening programs.
METHODS
Study Sample
An uncontrolled, paired sample before-and-after study was conducted with 40 participants
to assess the efficacy of the online decision aid (January through May 2017). Participants were
recruited from general pulmonology and smoking cessation clinics at the University of
Pennsylvania and were current or former smokers, aged 45-80 years, who had accrued at least a
20 pack-year smoking history, had smoked within the last 15 years, and had no prior history of
lung cancer or LDCT lung cancer screening. Participants were offered the opportunity to view the
decision aid at a computer in the clinic. No incentives were paid to participants. The study was
approved by the University of Pennsylvania IRB.
Data Collection
Participants were directed to complete a questionnaire about demographics, smoking
behaviors, knowledge of lung cancer screening, decisional conflict around screening, and
readiness to screen. The questionnaire was administered via Qualtrics (www.qualtrics.com) at the
University of Pennsylvania. Participants were asked to complete a “Before” questionnaire after
which they were navigated to shouldiscreen.com. Participants were familiarized with the website
layout and told to take their time in navigating through the general links on lung cancer screening
and the personalized risk calculator. Once participants had viewed the website to their satisfaction
they were directed to the “After” questionnaire.
Measures
Study questionnaires were adapted from the original validation study for
shouldiscreen.com, which assessed knowledge of benefits and harms of lung cancer screening,
decisional conflict, and concordance (Lau et al, 2015). These measures were originally based upon
the Ottawa Decision Support Framework (O’Connor et al., 2011).Knowledge was assessed by
asking a series of true-false questions about lung cancer risk factors (6 items), possible benefits (3)
and harms of lung cancer screening (3), and yes/no questions about screening eligibility for four
scenarios (4). There was an additional multiple-choice question asking what percentage of nodules
found on CT would not be cancerous with a 5-point probability response scale that ranged from
more than 90% to less than 5% (see Appendix-Table 2). The ten-item decisional conflict scale was
composed of four subscales: uncertainty, informed, values clarity, and support. A total score of 0
indicates no decisional conflict, whereas 100 shows extremely high conflict. Concordance was
measured between USPSTF recommendations and each participant’s preference as to whether or
not to undergo screening. This was assessed by the question Which option do you prefer now in
terms of lung cancer screening?, which was asked before and after exposure to shouldiscreen.com.
Participants who answered I prefer to screen and were also USPSTF eligible were deemed
concordant, as were participants ineligible for screening who answered I prefer not to screen.
Lastly, personalized lung cancer incidence risk was calculated on the shouldiscreen.com website
using an established risk model (Tammemägi et al., 2013).
Statistical Analysis
Our primary endpoints were improvement in knowledge and reduction in decisional
conflict after exposure to shouldiscreen.com as compared to baseline. With a total sample size of
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40 participants, we had 87% power to detect a 50% absolute difference in knowledge and
decisional conflict after exposure to shouldiscreen.com. The criterion for significance (alpha) was
set at 0.050. Paired t-tests were used to assess changes in knowledge and decisional conflict from
baseline to after exposure to shouldiscreen.com. All analyses were conducted using RStudio
(Version 1.0.143) and a p-value of < 0.05 was considered to be statistically significant.
RESULTS
Of 160 patients who completed an initial triage questionnaire between January and May
2017, 87 (54%) met inclusion criteria based on age and smoking status. Of the 62 participants that
were excluded, 34 (54.8%) were due to insufficient pack years, 14 (22.6%) due to computer
illiteracy, 7 (11.3%) due to lung cancer diagnosis, 3 (4.9%) due to visual or physical impairments
rendering them unable to use the computer, 2 (3.2%) due to inability to speak English, and 2 (3.2%)
due to having quit smoking more than 15 years ago. Of those eligible patients, 40 (46%) were
consented and enrolled (Figure 1). For those participants that were eligible but chose not to enroll,
their reasons included lack of time (77%), not interested in participating in research (19%), lack
of financial incentive (2%), and not feeling well (2%). Compared to those who did not enroll, those
who enrolled were more likely to be female (80% of those enrolled vs. 58% of those not enrolled).
The average enrolled participant was aged 57 (standard deviation 6.41 years), 80% were female,
and 62.5% were African-American (Table 1). 80% of participants were current smokers, and 35%
met USPSTF eligibility criteria for lung cancer screening. Of those participants that were ineligible
for screening, 50% were ineligible due to insufficient pack-years alone, 27% due to age alone, and
23% due to both insufficient pack-years and age. Regarding 6-year lung cancer risk, 45% of
participants had greater than 2% risk. Average time spent on the shouldiscreen.com decision aid
was 9.6 minutes (range 3 to 19 min), and average total time for questionnaire completion was 28
minutes (range 16 to 46 min).
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Table 1. Participant demographics [Number of participants (%)]
Total (N=40)
Age, mean (SD, range)
Female
Race
Black/African-American
White
American Indian/Alaskan Native
Other
Ethnicity
Hispanic or Latino
Not Hispanic or Latino
Education
Less than high school
High school graduate

57 (6.41, 45-69)
32 (80%)
25 (62.5%)
13 (32.5%)
1 (2.5%)
1 (2.5%)
1 (2.5%)
39 (97.5%)
5 (12.5%)
7 (17.5%)
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Some training after high school
Some college
College graduate
Postgraduate or professional degree
Smoking history
Current smoker
Quit within past 15 years
Pack years, mean, median (SD)
More than 30 pack-years
Lung cancer risk
<1% risk
1-2% risk
>2% risk
Eligible for screening by USPSTF criteria
Ineligible for screening by USPSTF criteria
Ineligible due to pack-years alone
Ineligible due to age alone
Ineligible due to both pack-years and age
Time spent on decision aid (minutes) + SD

7 (17.5%)
10 (25%)
8 (20%)
3 (7.5%)
32 (80%)
8 (20%)
34, 30 (13.63)
21 (52.5%)
8 (20%)
14 (35%)
18 (45%)
14 (35%)
26 (65%)
13 (50%)
7 (27%)
6 (23%)
9.6 + 4.1

Table 2 shows changes in knowledge, decisional conflict, and concordance, before and
after exposure to shouldiscreen.com. Knowledge increased after reviewing the decision aid in all
categories, including risk factors for lung cancer (3.58 to 4.30, p<0.01), benefits of lung cancer
screening (1.58 to 2.30, p<0.01), possible harms of screening (0.93 to 2.08, p<0.01), and eligibility
for screening (2.10 to 2.65, p<0.01). Additionally, mean overall decisional conflict was reduced
from 21.25 to 8.65 (p<0.01) with improvements primarily across the subcategories of information,
values clarity, and uncertainty.
Table 2. Before and After Results for Knowledge, Decisional Conflict Scale, and Concordance.

Knowledge
(overall)a

Before
(mean)

After
(mean)

p-values

Factors that increase the chances of
getting lung cancer [6]

3.58

4.30

<0.01

Possible benefits of lung cancer
screening [3]

1.58

2.30

<0.01

Possible harms of lung cancer
screening [3]

0.93

2.08

<0.01

2.10

2.65

<0.01

Which individuals would be
eligible for screening based on age,
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given that they all meet smoking
status and pack-year criteria? [1]

Decisional
conflictc

What percentage of lumps found on
your lung by the CT screening is
0.075
NOT going to be cancer?b [1]

0.325

0.0129

Overall decisional conflict

21.25

8.65

<0.01

Uncertainty subscale

4.2

1.45

<0.01

Informed subscale

9.5

3.55

<0.01

Values clarity subscale

4.45

1.65

<0.01

Support subscale

3.1

2.00

0.0569

15 (37.5%)

17 (42.5%)

0.820

Concordance among USPSTF
eligible

13 (32.5%)

11 (27.5%)

0.596

Concordance among USPSTF
ineligible

2 (5%)

6 (15%)

0.249

Concordanced Overall concordance

a-

The overall maximum score for the knowledge section is 14. The maximum score of each specific question is
specified in square parentheses.
b
-The figures presented for question 5 are the proportion of participants that answered correctly as there was only one
correct answer.
c
-Lower scores in the Decisional Conflict Scale signify less decisional conflict. A score of lower than 25 is associated
with implementing the decision. The overall score is the average of the subscales’ scores.
d
- Participants who preferred to get screened and were also eligible for screening based on USPSTF criteria were
deemed “concordant” as were participants not eligible for screening who preferred not to get screened. The figures
reported represent the frequency and proportion of those who were concordant.

Overall, preference to screen declined after navigating shouldiscreen.com, such that more
patients expressed a preference not to be screened for lung cancer. Specifically, concordance with
USPSTF guidelines decreased among those who were eligible to screen and increased among those
who did not yet meet eligibility criteria. However, these findings were not statistically significant.
DISCUSSION:
The web-based decision aid shouldiscreen.com was acceptable and feasible in a
socioeconomically and racially diverse group of smokers. Use of the aid improved lung cancer
screening knowledge and decreased decisional conflict, demonstrating its utility both as an
informational and decision guiding tool. At baseline, participants exaggerated the potential
benefits from screening, with only 7.5% correctly answering that >95% of lumps found on a
screening CT would be non-cancerous. After use of the decision aid, 32.5% of participants
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correctly answered this question, demonstrating a more accurate understanding of the potential
benefits and harms of screening. With this, we saw an overall preference for screening decline
after decision aid viewing. This may stem from the fact that benefits to screening are generally
well publicized whereas risks of screening, such as false positives, subsequent unnecessary testing
and possible complications, are less publicized. Use of the decision aid informed participants of
the realistic potential benefits and harms of screening, and this may have in turn discouraged them
from future screening. Future qualitative studies aimed at understanding patient attitudes towards
screening after use of decision aids would help to expand on this finding. This finding highlights
the importance of a structured tool in the shared decision-making process, as clinicians may be
highly variable in their own attitudes towards screening and may thus present risks and benefits to
patients in inconsistent or misleading ways (Ebell et al., 2018). The decision aid is not meant to
replace a shared decision-making conversation. It is a tool and a starting point for such discussions,
providing a patient with information and empowering them to assess their personalized risks and
benefits through a discussion with their physician.
Limitations
This study is limited to a brief interaction with a lung cancer screening decision-aid, and
its immediate impact on patient knowledge, attitude, and willingness to screen. The majority of
participants were female which is problematic given that lung cancer accounts for the highest
number of cancer deaths among African-American males in the U.S. (American Cancer Society,
2019). Many African-American males were eligible and approached for the study, but chose not
to participate. Future studies may benefit from offering a small monetary incentive to participants
to improve enrollment. Additionally, only 35% of participants were USPSTF eligible for
screening. The overall lung cancer risk was still higher than that seen in prior validation studies,
and the overall low screening eligibility would be expected to contribute to the low post-decision
aid willingness to screen as seen in our data.
One major limitation of this study was the inclusion of patients 45 to 80 years old, whereas
the current USPSTF criteria includes only patients 55 to 80 years old. The decision was made to
include younger patients for multiple reasons: for one, all of the participants, including those
younger than 55, had a >20 pack year smoking history and 80% of all participants were active
smokers. Therefore, it is likely that the majority of the participants under 55 will be eligible for
lung cancer screening in the coming decade if they continue to smoke. Additionally, patient
populations that are at increased risk for lung cancer are not represented in the current lung cancer
screening criteria (Wood et al., 2018). Research has shown that African-Americans have a higher
risk of lung cancer than whites even if they smoke less over time, and are diagnosed with lung
cancer at a younger age compared with whites (Aldrich et al., 2019). Given this, the current
USPSTF guidelines may be too conservative for African-American smokers, which comprised
62.5% of our participant population. Other risk models have been developed to try to expand
eligibility to such high-risk individuals that are not currently included in the USPSTF eligibility
criteria (Tammemägi et al., 2014). One such study including U.S. ever smokers age 50-80 showed
that a risk-based model for screening was associated with a greater number of lung cancer death
prevented over 5 years when compared with the current USPSTF model (Katki et al., 2016).
Since this was a single day study, there was no follow-up to see if knowledge gains were
durable or if participants who preferred to get screening ever actually did so. However, one recent
study demonstrated persistent knowledge gains one month after use of an online decision aid
(Mazzone et al., 2017). Another study followed patients three months after exposure to an online
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decision aid, and found heterogeneous screening behaviors (Reuland et al., 2018). Lastly, a
limitation to our study was the requirement that participants have experience with computers in
order to use the web-based tool. Of the 62 participants that were excluded, 14 (22.5%) were due
to computer illiteracy and 3 (4.8%) were due to visual or physical impairments rendering them
unable to use the computer. A recent study showed that use of audio in future decision aids may
improve patient participation for those unable to use computers (Hoffman et al., 2018). Expansion
to other languages would also allow for wider decision aid use. Since this study, a Spanishlanguage version has been developed and can be found at the following website:
www.shouldiscreen.com/Español/inicio. Future studies should address how best to effectively
integrate such an intervention into current clinical practices or a larger lung cancer screening
program, as a standalone decision aid could be viewed at home pre-visit or while waiting for a
physician in the office but would require even more literacy and autonomy on the part of the
patient.
Finally, this study was a single-group, pre-post study and future work should include a
usual care or control group in the design to determine if this decision aide is effective compared to
usual care.
Despite these limitations, this study shows that a web-based decision aid can be helpful
tool for increasing knowledge and reducing decision conflict about lung cancer screening in a
racial and ethnically diverse group of smokers in an urban academic clinic who are at increased
risk of lung cancer.
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